A Multicenter, Double‐Blind, Placebo‐Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis‐Related Pulmonary Arterial Hypertension—Results From the SPHInX Study

ABSTRACT The SPHInX study is the first‐ever randomized controlled trial (RCT) seeking to inform an area of equipoise regarding the efficacy of oral anticoagulation as adjunct therapy in systemic sclerosis‐related pulmonary arterial hypertension (SSc‐PAH). The SPHInX study was an Australian multicent...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mandana Nikpour, Alicia Calderone, Susanna M. Proudman, Dylan Hansen, Eli Gabbay, Nathan Dwyer, Gregory Keir, Vivek Thakkar, Peter K. K. Wong, Anne Keogh, Andrew Burns, David Prior, Harshal Nandurkar, David S. Celermajer, Joanne Sahhar, Rachelle Buchbinder, Wendy Stevens
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-04-01
Col·lecció:	Pulmonary Circulation
Matèries:	autoimmune connective tissue disease therapeutics
Accés en línia:	https://doi.org/10.1002/pul2.70331
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!